Frec Markets Inc’s AbbVie ABBV Stock Holding History

Frec Markets Inc’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.98M	Buy	19,777 +8,803	+80%	+$1.89M	0.45%	24
2026 Q1	$2.39M	Buy	10,974 +2,600	+31%	+$577K	0.41%	35
2025 Q4	$1.91M	Buy	+8,374	New	+$1.91M	0.56%	27

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Frec Markets Inc's ABBV Position: Q2 2026 in Review

Frec Markets Inc increased its AbbVie (ABBV) stake by 80% in Q2 2026, buying an estimated $1.89M and bringing the position to 19,777 shares worth $4.98M. The position accounts for 0.45% of the portfolio, ranked #24.

Frec Markets Inc first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. 4,209 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Frec Markets Inc held 19,777 shares of AbbVie worth $4.98M as of Q2 2026.
Frec Markets Inc bought 8,803 AbbVie shares in Q2 2026, an estimated $1.89M.
AbbVie made up 0.45% of Frec Markets Inc's portfolio in Q2 2026, its #24 holding.
Frec Markets Inc first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
4,209 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Frec Markets Inc's 13F filing for Q2 2026, filed 13 Aug 2026.